JPMorgan Chase & Co. Boosts Holdings in AnaptysBio, Inc. (NASDAQ:ANAB)
JPMorgan Chase & Co. boosted its holdings in AnaptysBio, Inc. (NASDAQ:ANAB – Free Report) by 240.6% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 114,939 shares of the biotechnology company’s stock after purchasing an additional 81,195 shares during the quarter. JPMorgan Chase & […]
JPMorgan Chase & Co. boosted its holdings in AnaptysBio, Inc. (NASDAQ:ANAB – Free Report) by 240.6% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 114,939 shares of the biotechnology company’s stock after purchasing an additional 81,195 shares during the quarter. JPMorgan Chase & […]
